H. Lee Moffitt Cancer Center and Research Institute — Clinical Trial Pipeline

H. Lee Moffitt Cancer Center and Research Institute has 11 registered trials in the index.

Trials (11)

Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents Phase 1 · H. Lee Moffitt Cancer Center and Research Institute
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma Phase 2 · H. Lee Moffitt Cancer Center and Research Institute
Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation Phase 2 · H. Lee Moffitt Cancer Center and Research Institute
Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL Phase 2 · H. Lee Moffitt Cancer Center and Research Institute
NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies Phase 2/3 · H. Lee Moffitt Cancer Center and Research Institute
Senior Adult Hepatobiliary Prehab Study N/A · H. Lee Moffitt Cancer Center and Research Institute
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab Phase 2 · H. Lee Moffitt Cancer Center and Research Institute
Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free N/A · H. Lee Moffitt Cancer Center and Research Institute
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma Phase 2 · H. Lee Moffitt Cancer Center and Research Institute
TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC Phase 1 · H. Lee Moffitt Cancer Center and Research Institute
Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer N/A · H. Lee Moffitt Cancer Center and Research Institute

Related landscapes

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.